Thomas Klonisch

Dr. Thomas Klonisch

Department of Human Anatomy and Cell Science, Rady Faculty of Medicine, Max Rady College of Medicine, University of Manitoba, 130-745 William Avenue, Winnipeg, MB R3E 0J9, Canada
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ABamir barzegar behrooz
amir barzegar behrooz
ZTZahra Talaie
Zahra Talaie
FJFatemeh Jusheghani
Fatemeh Jusheghani
Marek J. ŁosMarek J. Łos
Marek J. Łos
Thomas KlonischThomas Klonisch
Thomas Klonisch
Saeid GhavamiSaeid Ghavami
Saeid Ghavami
Glioblastoma (GBM) is a devastating type of brain tumor, and current therapeutic treatments, including surgery, chemotherapy, and radiation, are palliative at best. The design of effective and targeted chemotherapeutic strategies for the treatment of GBM require a thorough analysis of specific signaling pathways to identify those serving as drivers of GBM progression and invasion. The Wnt/β-catenin and PI3K/Akt/mTOR (PAM) signaling pathways are key regulators of important biological functions that include cell proliferation, epithelial–mesenchymal transition (EMT), metabolism, and angiogenesis. Targeting specific regulatory components of the Wnt/β-catenin and PAM pathways has the potential to disrupt critical brain tumor cell functions to achieve critical advancements in alternative GBM treatment strategies to enhance the survival rate of GBM patients. In this review, we emphasize the importance of the Wnt/β-catenin and PAM pathways for GBM invasion into brain tissue and explore their potential as therapeutic targets.

1 April 2018 in Pharmacology & Therapeutics
Verified
Journal Article
Closed access
SHSabine Hombach-Klonisch
Sabine Hombach-Klonisch
MMMaryam Mehrpour
Maryam Mehrpour
SGSaeid Ghavami
Saeid Ghavami
CHCraig Harlos
Craig Harlos
MPMarshall Pitz
Marshall Pitz
Saeid GhavamiSaeid Ghavami
Saeid Ghavami

30 March 2017 in Autophagy
Verified
Journal Article
Open access
PMpooneh mokarram
pooneh mokarram
MAMohammed Albokashy
Mohammed Albokashy
MZMaryam Zarghooni
Maryam Zarghooni
MMMohammad Amin Moosavi
Mohammad Amin Moosavi
ZSZahra Sepehri
Zahra Sepehri
Saeid GhavamiSaeid Ghavami
Saeid Ghavami
Colorectal cancer (CRC), despite numerous therapeutic and screening attempts, still remains a major life-threatening malignancy. CRC etiology entails both genetic and environmental factors. Macroautophagy/autophagy and the unfolded protein response (UPR) are fundamental mechanisms involved in the regulation of cellular responses to environmental and genetic stresses. Both pathways are interconnected and regulate cellular responses to apoptotic stimuli. In this review, we address the epidemiology and risk factors of CRC, including genetic mutations leading to the occurrence of the disease. Next, we discuss mutations of genes related to autophagy and the UPR in CRC. Then, we discuss how autophagy and the UPR are involved in the regulation of CRC and how they associate with obesity and inflammatory responses in CRC. Finally, we provide perspectives for the modulation of autophagy and the UPR as new therapeutic options for CRC treatment.

1 August 2006 in The American Journal of Pathology
Verified
Journal Article
Closed access
SHSabine Hombach-Klonisch
Sabine Hombach-Klonisch
JBJoanna Bialek
Joanna Bialek
BTBogusz Trojanowicz
Bogusz Trojanowicz
EWEkkehard Weber
Ekkehard Weber
HHHans-Jürgen Holzhausen
Hans-Jürgen Holzhausen
Thomas KlonischThomas Klonisch
Thomas Klonisch

1 November 2009 in Trends in Molecular Medicine
Verified
Journal Article
Closed access
Thomas KlonischThomas Klonisch
Thomas Klonisch
RDRégen Drouin
Régen Drouin

16 December 2004 in Journal of Molecular Endocrinology
Verified
Journal Article
Closed access
SHS Hombach-Klonisch
S Hombach-Klonisch
AKA Kehlen
A Kehlen
PFPaul A Fowler
Paul A Fowler
BHB Huppertz
B Huppertz
JJJ F Jugert
J F Jugert
Thomas KlonischThomas Klonisch
Thomas Klonisch
Information on the regulation of steroid hormone receptors and their distinct functions within the human endometrial epithelium is largely unavailable. We have immortalized human primary endometrial epithelial cells (EECs) isolated from a normal proliferative phase endometrium by stably transfecting the catalytic subunit (hTERT) of the human telomerase complex and cultured these hTERT-EECs now for over 350 population doublings. Active hTERT was detected in hTERT-EECs employing the telomerase repeat amplification assay protocol. hTERT-EECs revealed a polarized, non-invasive epithelial phenotype with apical microvilli and production of a basal lamina when grown on a three-dimensional collagen–fibroblast lattice. Employing atomic force microscopy, living hTERT-EECs were shown to produce extracellular matrix (ECM) components and ECM secretion was modified by estrogen and progesterone (P4). hTERT-EECs expressed inducible and functional endogenous estrogen receptor-alpha (ER-alpha) as demonstrated by estrogen response element reporter assays and induction of P4 receptor (PR). P4 treatment down-regulated PR expression, induced MUC-1 gene activity and resulted in increased ER-beta transcriptional activity. Gene activities of cytokines and their receptors interleukin (IL)-6, leukemia inhibitory factor (LIF), IL-11 and IL-6 receptor (IL6-R), LIF receptor and gp130 relevant to implantation revealed a 17 beta-estradiol (E2)-mediated up-regulation of IL-6 and an E2- and P4-mediated up-regulation of IL6-R in hTERT-EECs. Thus, hTERT-EECs may be regarded as a novel in vitro model to investigate the role of human EECs in steroid hormone-dependent normal physiology and pathologies, including implantation failure, endometriosis and endometrial cancer.